B2 - Health technology assessments: A global overview

Auditorium 2

Organised by the FIP SIG on Pharmacy Practice Research in collaboration with FIP’s Health and Medicines Information Section


Dalia Dawoud, Cairo University, Egypt and Victoria García-Cárdenas, FIP Pharmacy Practice Research Special Interest Group, Australia


This session will provide an introduction to health technology assessment (HTA) and its role in supporting decision making about access to health technologies including digital applications and companion diagnostics. An overview of the HTA process and its different models will be given as well as examples of the different country cases.


  1. HTA: The “What?”, “Why?” and “How?”
    Clémence Perraudin, Community Pharmacy Centre Department of Ambulatory Care and Community Medicine, Switzerland
  2. Implementation and adoption of HTA around the world
    Juan Carlos Rejon, Andalusian Agency for Health Technology Assessment (AETSA), Spain
  3. HTA in action
    Dyfrig Hughes, Bangor University, UK

Learning Objectives

At the end of this session, participants will be able to:

  1. To define health technology assessment and list steps involved in undertaking it.
  2. To explain the importance of assessing the value of new technologies before adopting them on a health-system level 

Type of session: Knowledge-based